Bristol-Myers Squibb to Acquire Celgene
Open Letter to Stockholders
Read Bristol-Myers Squibb’s Board of Directors’ Letter to the company stockholders regarding the value of the planned acquisition of Celgene.
Building Toward a Translational Future
Saurabh Saha leads the translational medicine team and returns to the Boston-area to build out the new R&D facility in Cambridge.
Information on the Bristol-Myers Squibb and Celgene Transaction
Learn more about Bristol-Myers Squibb’s planned acquisition of Celgene.
Scientists on the Move
As an R&D footprint expands, several colleagues saw an opportunity to explore new areas of science.
News & Perspectives
People
Our R&D Team
Looking for Answers?
Quick links to helpful resources.
Clinical Trial Information for Researchers
Clinical trials and research are a critical part of bringing new medicines to patients.
Medical Information for Healthcare Providers
Information and resources to assist with caring for patients.
Help Paying for Your Medicines
If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help.